Johnson &amp; Johnson to Pay $25.4 Billion for Guidant
85267
Johnson &amp; Johnson agreed to acquire Guidant Corp. for $25.4 billion, adding electrical devices for treating heart disease to a lineup of thousands of health products including Band-Aids and cardiac stents.
595193
Johnson &amp; Johnson (JNJ:NYSE - news - research) reportedly is negotiating to buy Guidant (GDT:NYSE - news - research) for $24 billion, a transaction that would unite two big manufacturers of coronary devices.
134189
Johnson & Johnson  on Wednesday said it agreed to buy Guidant Corp. , for &#36;25.4 billion in cash and stock, giving the healthcare products maker a foothold in the fast-growing market for implantable devices that regulate heartbeats.
580857
Johnson & Johnson's $25.4 billion takeover of Guidant Corp. and the $35 billion union of Sprint Corp. and Nextel Communications Inc. are leading the busiest quarter for mergers in more than four years. -The Washington Post
680919
Johnson &amp; Johnson, the maker of Band- Aids and other products, is in talks to buy Guidant Corp. for more than $24 billion, the New York Times reported, citing unidentified executives familiar with the talks.
565121
Johnson & Johnson, the pharmaceutical and health care giant, is near a deal to buy Guidant, one of the nation's largest makers of devices to treat heart and circulatory illnesses.
16804
Johnson &amp; Johnson Chief Executive Officer William Weldon plans to use the $25 billion purchase of defibrillator maker Guidant Corp.
360773
Johnson &amp; Johnson, whose board is meeting today, is close to agreeing to pay $24 billion for Guidant Corp., the world&#39;s second-biggest maker of heart-rhythm devices, people familiar with the matter said.
312826
Johnson &amp; Johnson announced that it will acquire Guidant Corp., one of the world&#39;s top makers of cardiac devices, for $25.4 billion US.
542616
A U.S. court dealt a blow to Johnson & Johnson in its $5.5 billion lawsuit over the sale of Guidant Corp to Boston Scientific Corp, dismissing some claims and only allowing part of the case to proceed.
341615
Johnson &amp; Johnson&#39;s$25.4bn purchase of Guidant, a medical device maker, will give the big US medical group a range of fast-growing products that manage patients&#39; heart rhythms, a move that will shake up the US medical device industry.
670784
NEW YORK - US health titan Johnson and Johnson is in &quot;advanced negotiations&quot; for a 24-billion-dollar takeover of US heart device manufacturer Guidant, the New York Times said.
202527
Johnson &amp; Johnson has made a deal to buy Guidant Corp. a producer of medical equipment for patients with heart and circulatory illnesses, for $24 billion in stock and cash.
388933
Washington - United States health titan Johnson and Johnson has reached a deal to acquire American heart device manufacturer Guidant, in a stock-and-cash deal valued at $23.9-billion, based on $76 per share, the companies said in a statement early on
340033
Johnson & Johnson is in advanced negotiations to acquire Guidant, one of the nation's largest makers of devices to treat heart illnesses, for more than $24 billion.
169716
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Wednesday night that it would acquire medical equipment maker Guidant (GDT:NYSE - news - research) for $23.9 billion in cash and stock.
39192
Win-win? That could be the case for Ronald W. Dollens if Johnson &amp; Johnson (nyse: JNJ - news - people ) has its way. Dollens is president and chief executive of Guidant (nyse: GDT - news - people ), J&amp;J&#39;s takeover target.